Skip to main content

Table 2 Demographic and clinical characteristics of patients with asthma and healthy controls

From: Antibody blockade of Dectin-2 suppresses house dust mite-induced Th2 cytokine production in dendritic cell- and monocyte-depleted peripheral blood mononuclear cell co-cultures from asthma patients

Determinants Normal range Patients with asthma Healthy controls
Number   12 4
Age in years, mean (SD) 50.1 (11.4) 54.3 (8.8)
Sex, male, n (%) 7 (58.3) 2 (50.0)
Disease duration in years, medium (range) 20.0 (0.5–59)
Laboratory profiles
 Total eosinophil count (/μL), mean (SD) <450.0 340.0 (236.6) 124.8 (42.6)
 Total IgE (kU/L), mean (SD) <200.0 574.3 (1126.1) 15.5 (16.5)
 Specific anti-D. pteronyssinus IgE (kU/L), mean (SD) <0.5 11.1 (11.1) 0.09 (0.08)
Pulmonary function test
 % of predicted FEV1, mean (SD) >80.0 81.1 (14.9)
 % of predicted FEV1/FVC, mean (SD) >70.0 69.7 (9.5)
Anti-asthma drugs
 Bronchodilator, n (%)   12 (100.0)
 Leukotriene antagonist, n (%)   2 (16.7)
 Corticosteroid, n (%)   4 (33.3)
 Asthma Control Test score, mean (range)a   18.3 (12–24)
  1. Abbreviation: FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, SD Standard deviation
  2. aAsthma control test score ranges from 5 to 25, with higher scores reflecting greater asthma control